Effect of antispasmodic agents, alone or in combination, in the treatment of Irritable Bowel Syndrome: Systematic review and meta-analysis

Schmulson, 2010, Prevalence and clinical characteristics of the IBS subtypes according to the Rome III criteria in patients from a clinical, multicentric trial. A report from the Mexican IBS Working Group, Rev Gastroenterol Mex, 75, 427 Drossman, 2005, A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator, Gastroenterology, 128, 580, 10.1053/j.gastro.2004.12.006 Thompson, 1999, Functional bowel disorders and functional abdominal pain, Gut, 45, 43, 10.1136/gut.45.2008.ii43 Camilleri, 1992, The irritable bowel syndrome: mechanisms and a practical approach to management, Ann Intern Med, 116, 1001, 10.7326/0003-4819-116-12-1001 Kellow, 2006, Applied principles of neurogastroenterology: physiology/motility sensation, Gastroenterology, 130, 1412, 10.1053/j.gastro.2005.08.061 Drossman, 2002, AGA technical review on irritable bowel syndrome, Gastroenterology, 123, 2108, 10.1053/gast.2002.37095 Lesbros-Pantoflickova, 2004, Metaanalysis: the treatment of irritable bowel syndrome, Aliment Pharmacol Ther, 20, 1253, 10.1111/j.1365-2036.2004.02267.x Poynard, 1994, Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome, Aliment Pharmacol Ther, 8, 499, 10.1111/j.1365-2036.1994.tb00322.x Brandt, 2002, Systematic review on the management of irritable bowel syndrome in North America, Am J Gastroenterol, 97, S7 Tack, 2006, Systematic review: the efficacy of treatments for irritable bowel syndrome--a European perspective, Aliment Pharmacol Ther, 24, 183, 10.1111/j.1365-2036.2006.02938.x Sacks, 1987, Meta-analyses of randomized controlled trials, N Engl J Med, 316, 450, 10.1056/NEJM198702193160806 Jadad, 1993, A high-yield strategy to identify randomized controlled trials for systematic reviews, Online J Curr Clin Trials, 33 Moher, 1995, Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists, Control Clin Trials, 16, 62, 10.1016/0197-2456(94)00031-W Moher, 1996, Assessing the quality of randomized controlled trials. Current issues and future directions, Int J Technol Assess Health Care, 12, 195, 10.1017/S0266462300009570 Higgins, 2003, Measuring inconsistency in metaanalyses, Br Med J, 327, 557, 10.1136/bmj.327.7414.557 Demets, 1987, Methods for combining randomized clinical trials: strengths and limitations, Stat Med, 6, 341, 10.1002/sim.4780060325 Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, Br Med J, 315, 629, 10.1136/bmj.315.7109.629 McQuay, 1997, Using numerical results from systematic reviews in clinical practice, Ann Intern Med, 126, 712, 10.7326/0003-4819-126-9-199705010-00007 Ford, 2008, Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and metaanalysis, Br Med J, 337, 313, 10.1136/bmj.a2313 Clave, 2011, Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome, Aliment Pharmacol Ther, 34, 432, 10.1111/j.1365-2036.2011.04730.x Wittmann, 2010, Clinical trial: the efficacy of alverine citrate/simethicone combination on abdominal pain/discomfort in irritable bowel syndrome--a randomized, double-blind, placebo-controlled study, Aliment Pharmacol Ther, 31, 615, 10.1111/j.1365-2036.2009.04216.x Glass, 1976, Primary, Secondary, and Meta-Analysis of Research, Educational Researcher, 5, 3, 10.3102/0013189X005010003 Remes-Troche, 2011, Pinaverium bromide bromide plus simethicone is effective on abdominal pain, in a 12-week randomized placebo-controlled trial in IBS. A report from the Mexican IBS-Working Group, Gastroenterology, 140, M1332 Schmulson, 2011, Can pinaverium bromide bromide plus simethicone improve bloating and objective abdominal distention during a 12-week randomized-clinical trial in IBS?. A report from the Mexican IBSWorking Group, Gastroenterology, 140, M1327 Ford, 2009, Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis, Am J Gastroenterol, 104, 1831, 10.1038/ajg.2009.223 Smeeth, 1999, Numbers needed to treat derived from meta-analyses--sometimes informative, usually misleading, BMJ, 318, 1548, 10.1136/bmj.318.7197.1548 Levy, 1977, Pinaverium bromide bromide and functional colonic disease (double-blind study, Sem Hop Ther, 53, 372 Delmont, 1981, The value of adding an antispasmodic musculotropic agent in the treatment of painful constipation in functional colopathies with bran. Double-blind study, Med Chir Dig, 10, 365 Connell, 1965, Physiological and clinical assessment of the effect of the musculotropic agent mebeverine on the human colon, Br Med J, 2, 848, 10.1136/bmj.2.5466.848 Tasman-Jones, 1973, Mebeverine in patients with the irritable colon syndrome: double blind study, N Z Med J, 77, 232 Berthelot, 1981, Etude controleÂe en double aveugle DUSPATALIN (Mebeverine) contre placebo, dans le traitement du colon irritable, Gaz Med France, 88, 2341 Kruis, 1986, Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome, Digestion, 34, 196, 10.1159/000199329 Secco, 1983, Controlled clinical study of the action of mebeverine hydrochloride in the treatment of irritable colon, Minerva Med, 74, 699 Enck, 2005, Determination of placebo effect in irritable bowel syndrome, Dtsch Med Wochenschr, 130, 1934, 10.1055/s-2005-872605 Barbier, 1981, Double blind controlled trial of a new colonic antispasmodic agent, actylonium bromide, Ars Medici Revue Internationale De Therapie Pratique, 36, 1879 Baldi, 1991, Clinical and functional evaluation of the efficacy of otilonium bromide: a multicenter study in Italy, Ital J Gastroenterol, 23, 60 Battaglia, 1998, Otilonium bromide in irritable bowel syndrome: a double-blind, placebo-controlled, 15-week study, Aliment Pharmacol Ther, 12, 1003, 10.1046/j.1365-2036.1998.00397.x Castiglione, 1991, Therapeutic strategy for the irritable bowel syndrome, Ital J Gastroenterol, 23, 53 Glende, 2002, Extended analysis of a double-blind, placebo-controlled, 15-week study with otilonium bromide in irritable bowel syndrome, Eur J Gastroenterol Hepatol, 14, 1138, 10.1097/00042737-200212000-00008 Ritchie, 1979, Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk, Br Med J, 1, 376, 10.1136/bmj.1.6160.376 Nigam, 1984, Different therapeutic regimens in irritable bowel syndrome, J Assoc Physicians India, 32, 1041 Shafer, 1990, Behandlung des colon irritabile, Fortschr Med, 25, 488 Fielding, 1980, Double blind trial of trimebutine in the irritable bowel syndrome, Ir Med J, 73, 377 Moshal, 1979, A clinical trial of trimebutine (Mebutin) in spastic colon, J Int Med Res, 7, 231, 10.1177/030006057900700311 Luttecke, 1978, A trial of trimebutine in spastic colon, J Int Med Res, 6, 86, 10.1177/030006057800600202 Luttecke, 1980, A three-part controlled study of trimebutine in the treatment of irritable colon syndrome, Curr Med Res Opin, 6, 437, 10.1185/03007998009109464 Mitchell, 2002, Alverine citrate fails to relieve the symptoms of irritable bowel syndrome: results of a double-blind, randomized, placebo-controlled trial, Aliment Pharmacol Ther, 16, 1187, 10.1046/j.1365-2036.2002.01277.x Wittmann, 2010, Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome-a randomized, double-blind, placebo-controlled study, Aliment Pharmacol Ther, 31, 615, 10.1111/j.1365-2036.2009.04216.x Page, 1981, Treatment of the irritable bowel syndrome with Bentyl (dicyclomine hydrochloride), J Clin Gastroenterol, 3, 153, 10.1097/00004836-198106000-00009